Does VALGANCICLOVIR Cause Therapy partial responder? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Therapy partial responder have been filed in association with VALGANCICLOVIR (VALGANCICLOVIR). This represents 0.1% of all adverse event reports for VALGANCICLOVIR.
8
Reports of Therapy partial responder with VALGANCICLOVIR
0.1%
of all VALGANCICLOVIR reports
2
Deaths
2
Hospitalizations
How Dangerous Is Therapy partial responder From VALGANCICLOVIR?
Of the 8 reports, 2 (25.0%) resulted in death, 2 (25.0%) required hospitalization, and 4 (50.0%) were considered life-threatening.
Is Therapy partial responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VALGANCICLOVIR. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does VALGANCICLOVIR Cause?
Off label use (1,882)
Cytomegalovirus infection (1,091)
Drug ineffective (886)
Neutropenia (809)
Leukopenia (574)
Drug resistance (524)
Cytomegalovirus viraemia (447)
Pancytopenia (434)
Cytomegalovirus infection reactivation (374)
Death (359)
What Other Drugs Cause Therapy partial responder?
CYCLOPHOSPHAMIDE (1,397)
RITUXIMAB (1,219)
DEXAMETHASONE (1,199)
PREDNISONE (1,176)
PEMBROLIZUMAB (1,125)
CARBOPLATIN (1,096)
DOXORUBICIN (834)
METHOTREXATE (775)
VINCRISTINE (707)
ETOPOSIDE (670)
Which VALGANCICLOVIR Alternatives Have Lower Therapy partial responder Risk?
VALGANCICLOVIR vs VALIUM
VALGANCICLOVIR vs VALPROATE
VALGANCICLOVIR vs VALPROIC ACID
VALGANCICLOVIR vs VALPROMIDE
VALGANCICLOVIR vs VALSARTAN